SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences - Quaterly Results

28 Oct 2021 Evaluate
The company witnessed a 5.54% growth in the revenue at Rs. 565.94 millions for the quarter ended September 2021 as compared to Rs. 536.24 millions during the year-ago period.A humble growth in net profit of 16.25% reported in the quarter ended September 2021 to Rs. 117.74  millions from Rs. 101.28 millions.Operating Profit saw a handsome growth to 184.57 millions from 179.52 millions in the quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 565.94 536.24 5.54 1150.99 925.01 24.43 2084.77 1694.25 23.05
Other Income 13.22 4.75 178.32 23.54 8.93 163.61 16.48 29.27 -43.70
PBIDT 184.57 179.52 2.81 376.38 316.87 18.78 736.41 556.48 32.33
Interest 3.53 15.73 -77.56 7.20 25.37 -71.62 39.47 50.34 -21.59
PBDT 181.04 163.79 10.53 369.18 291.50 26.65 644.16 506.14 27.27
Depreciation 23.22 23.91 -2.89 46.20 47.52 -2.78 96.33 93.85 2.64
PBT 157.82 139.88 12.83 322.98 243.98 32.38 547.83 412.29 32.87
TAX 40.08 38.60 3.83 82.87 66.47 24.67 148.82 100.05 48.75
Deferred Tax 2.34 0.36 550.00 -4.69 -0.83 465.06 -14.83 -18.00 -17.61
PAT 117.74 101.28 16.25 240.11 177.51 35.27 399.01 312.24 27.79
Equity 85.07 85.07 0.00 85.07 85.07 0.00 85.07 85.07 0.00
PBIDTM(%) 32.61 33.48 -2.58 32.70 34.26 -4.54 35.32 32.85 7.54

Hester Biosciences Share Price

1649.65 11.45 (0.70%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×